nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens
|
Altvater, Bianca |
|
2011 |
61 |
3 |
p. 385-396 |
artikel |
2 |
Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany
|
Ullrich, Evelyn |
|
2011 |
61 |
3 |
p. 433-443 |
artikel |
3 |
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
|
Rahma, Osama E. |
|
2011 |
61 |
3 |
p. 373-384 |
artikel |
4 |
A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein
|
Kountouras, Jannis |
|
2011 |
61 |
3 |
p. 445-446 |
artikel |
5 |
Design of immunogenic and effective multi-epitope DNA vaccines for melanoma
|
Cho, Hyun-Il |
|
2011 |
61 |
3 |
p. 343-351 |
artikel |
6 |
Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells
|
Conroy, Helen |
|
2011 |
61 |
3 |
p. 425-431 |
artikel |
7 |
HP-NAP new therapy for bladder cancer: numquam periculum sine periculo vincitur
|
Codolo, Gaia |
|
2011 |
61 |
3 |
p. 447-448 |
artikel |
8 |
Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions
|
Ogino, Toshitatsu |
|
2011 |
61 |
3 |
p. 409-424 |
artikel |
9 |
Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer
|
Yang, Shao-Bo |
|
2011 |
61 |
3 |
p. 335-342 |
artikel |
10 |
In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging
|
Provinciali, Mauro |
|
2011 |
61 |
3 |
p. 363-371 |
artikel |
11 |
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
|
Ge, Yingzi |
|
2011 |
61 |
3 |
p. 353-362 |
artikel |
12 |
Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice
|
Gritzapis, Angelos D. |
|
2011 |
61 |
3 |
p. 397-407 |
artikel |
13 |
Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. ‘HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response’
|
Jackson, Andrew M. |
|
2011 |
61 |
3 |
p. 449-451 |
artikel |
14 |
Role of CD44 in lymphokine-activated killer cell-mediated killing of melanoma
|
Sun, Jingping |
|
2011 |
61 |
3 |
p. 323-334 |
artikel |
15 |
SCF and TLR4 ligand cooperate to augment the tumor-promoting potential of mast cells
|
Wei, Jing-Jing |
|
2011 |
61 |
3 |
p. 303-312 |
artikel |
16 |
Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients
|
Ochsenreither, Sebastian |
|
2011 |
61 |
3 |
p. 313-322 |
artikel |